• PDF: Delivered by email usually within 48 UK business hours.

AmerisourceBergen Corporation (ABC) - Pharmaceuticals & Healthcare
Deals and Alliances Profile

  • Publication Date:March 2012
  • Publisher:GlobalData
  • Product Type: Report
  • Pages:113

AmerisourceBergen Corporation (ABC) - Pharmaceuticals & Healthcare Deals and Alliances Profile

Summary

AmerisourceBergen Corporation (AmerisourceBergen) is a pharmaceutical services provider, which is engaged in drug distribution and manufacturing related services including pharmaceutical packaging, pharmacy automation, supply management software, inventory management, consulting and logistics services and physician education. It offers the complete range of branded and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment and related services. In pharmaceutical supply channel, the company serves both healthcare providers and pharmaceutical manufacturers. Its operations are concentrated in the US, Canada and the UK. It is headquartered in Pennsylvania, the US.

AmerisourceBergen Corporation (ABC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals and Healthcare eTrack deals database, and primary and secondary research.

Scope

  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

  • Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

This report covers the following industry codes:

  • SIC Code: 5122
  • NAICS Code: 42221
  • AmerisourceBergen Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
  • AmerisourceBergen Corporation, Pharmaceuticals & Healthcare Deals By Type, 2006 to YTD 2012
  • AmerisourceBergen Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2006 to YTD 2012
  • AmerisourceBergen Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2006 to YTD 2012
  • AmerisourceBergen Corporation, Pharmaceuticals & Healthcare, Medical Devices Deals, 2006 to YTD 2012
  • AmerisourceBergen Corporation, Pharmaceuticals & Healthcare, Partnerships, Deals By Year Vs Deal Value Vs Upfront Payment, 2006 to YTD 2012
  • AmerisourceBergen Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2006 to YTD 2012
  • AmerisourceBergen Corporation, Pharmaceuticals & Healthcare, Deal Details
  • Partnerships
  • AmerisourceBergen Forms Joint Venture With Kindred Healthcare
  • Sciele Pharma Partners With AmerisourceBergen
  • Debt Offering
  • AmerisourceBergen Completes Public Offering Of 3.5% Senior Notes Due 2021 For $500 Million
  • AmerisourceBergen Completes Public Offering Of Senior Notes Due 2019 For $400 million
  • Acquisition
  • AmerisourceBergen Completes Acquisition Of TheraCom For $250 Million
  • AmerisourceBergen Acquires IntrinsiQ For $35 Million
  • AmerisourceBergen Acquires Innomar Strategies
  • AmerisourceBergen Acquires Bellco Health
  • AmerisourceBergen Acquires Xcenda
  • AmerisourceBergen Acquires Access
  • AmerisourceBergen Acquires IgG of America
  • AmerisourceBergen Acquires Health Advocates
  • AmerisourceBergen Acquires Rep-Pharm
  • AmerisourceBergen Acquires Asenda Pharmaceutical
  • AmerisourceBergen Acquires Brecon Pharmaceuticals
  • AmerisourceBergen Acquires Network for Medical Communications & Research
  • AmerisourceBergen Corporation - Key Competitors
  • Key Employees
  • Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Recent Developments
    • Strategy And Business Planning
    • Jun 02, 2009: AmerisourceBergen Purchases Innomar Strategies
    • Financial Announcements
    • Nov 01, 2011: AmerisourceBergen Reports Revenue Of $20.4 Billion In Q4 Fiscal 2011
    • Jul 28, 2011: AmerisourceBergen Reports Revenue Of $20.16 Billion For Q3 Fiscal 2011
    • May 06, 2011: AmerisourceBergen Reports Revenue Of $19.8 Billion For Q2 Fiscal 2011
    • Feb 04, 2011: AmerisourceBergen Reports Net Income Of $160.5 Million For Q1 Fiscal 2011
    • Nov 25, 2009: AmerisourceBergen Reports Revenue Of $71.76 Billion For Fiscal 2009
    • Aug 06, 2009: AmerisourceBergen Reports Revenue Of $18.4 Billion For Q3 Fiscal 2009
    • May 08, 2009: AmerisourceBergen Reports Revenue Of $17.3 Billion For Q2 Fiscal 2009
    • Oct 30, 2008: Amerisourcebergen (Abc) Reports $0.73 Diluted Eps From Continuing Operations, Up 18 Percent, And Revenue Up 5 Percent In The September Quarter
    • Jul 24, 2008: Amerisourcebergen (Abc) Reports Record Revenue, Up 10 Percent, And $0.70 In Diluted Eps From Continuing Operations For The June Quarter
    • Jan 24, 2008: Amerisourcebergen (Abc) Reports Diluted Earnings Per Share Of $0.66 For The December Quarter And Raises Operating Revenue Growth Expectations For Fiscal Year 2008
    • Dec 03, 2007: Amerisourcebergen Extends Long-Term Relationship With Medco; Reaffirms Fiscal 2008 Earnings Per Share Expectations; And Provides Guidance For December Quarter
    • Nov 28, 2007: Amerisourcebergen Files Annual Report On Form 10-K
    • Nov 01, 2007: Amerisourcebergen Reports Diluted Earnings Per Share From Continuing Operations Of $0.63 For The September Quarter And $2.63 For Fiscal Year 2007
    • Sep 17, 2007: Amerisourcebergen Announces Streamlined Organization, Confirms Fy 2007 Diluted Earnings Per Share Expectations, And Says Fy 2008 Is Expected To Be In Line With Long-Term Goals
    • Jul 26, 2007: Amerisourcebergen Reports Record Quarterly Diluted Earnings Per Share Of $0.69
    • Apr 25, 2007: Amerisourcebergen Reports Record Quarterly Diluted Earnings Per Share Of $0.68
    • Jan 24, 2007: Amerisourcebergen Reports Diluted Earnings Per Share Of $0.63 And Record Operating Revenue Of $15.7 Billion For December Quarter
    • Jan 08, 2007: Amerisourcebergen Raises Operating Revenue Growth Expectations For December Quarter And Fiscal Year 2007
    • Nov 02, 2006: Amerisourcebergen Reports Record Operating Revenue Of $14.6 Billion And $0.61 Diluted Earnings Per Share For The September Quarter
    • Jul 25, 2006: Amerisourcebergen Reports Record Operating Revenue Of $14.4 Billion And $0.58 Diluted Earnings Per Share For The June Quarter; Company Raises Expectations For Fiscal 2006 Diluted Earnings Per Share To A Range Of $2.16 To $2.24
    • Apr 26, 2006: Amerisourcebergen Reports Record Operating Revenue Of $14 Billion And $0.61 Diluted Earnings Per Share From Continuing Operations For The March Quarter
    • Jan 25, 2006: Amerisourcebergen Reports December Quarter Results, With Diluted Earnings Per Share From Continuing Operations Of $0.47; Record Operating Revenue Of $13.5 Billion, Up 11 Percent
    • Jan 10, 2006: Amerisourcebergen Raises Operating Revenue Growth Expectations And Reaffirms Diluted Eps Guidance For The December Quarter And Fiscal Year 2006 At Jp Morgan Conference
    • Dec 01, 2005: Amerisourcebergen Reaffirms Guidance For Fy2006 And Provides Detailed Outlook For The December Quarter; Webcasts Investor Day Meeting Today
    • Nov 03, 2005: Amerisourcebergen Reports Record Operating Revenue And Cash Flow In Year-End Results; Company Expects Diluted Earnings Per Share Of $3.95 To $4.25 For Fiscal 2006
    • Jul 21, 2005: Amerisourcebergen Reports June Quarterly Results With $0.96 Diluted Earnings Per Share From Continuing Operations
    • Apr 21, 2005: Amerisourcebergen Reports March Quarterly Results, With Diluted Earnings Per Share From Continuing Operations Of $0.91
    • Mar 28, 2005: Amerisourcebergen Expects Diluted Eps From Continuing Operations Of $3.10 To $3.50 For Fy 2005 And $0.75 To $0.85 For The March Quarter
    • Jan 25, 2005: Amerisourcebergen Reports December Quarterly Results, With Diluted Earnings Per Share From Continuing Operations Of $0.66
    • Jan 11, 2005: Amerisourcebergen Confirms Diluted Eps From Continuing Operations Of $4.00 To $4.10 For Fy 2005 And $0.60 To $0.65 For The December Quarter
    • Dec 22, 2004: Amerisourcebergen Expects Diluted Eps From Continuing Operations Of $4.00 To $4.10 For Fy 2005 And $0.60 To $0.65 For The December Quarter
    • Nov 02, 2004: Amerisourcebergen Reports Quarterly And Year-End Results, Including Strong Cash Flow From Operations, And Affirms Guidance For Fiscal 2005
    • Oct 05, 2004: Amerisourcebergen Expects Diluted Earnings Per Share To Be Between $3.95 And $4.05 For Fy 2004, Excluding Special Items, And Between $4.20 And $4.30 For Fy 2005
    • Jul 22, 2004: Amerisourcebergen Reports Strong Cash Flow From Operations And Solid Earnings Performance For The June Quarter
    • Apr 26, 2004: Amerisourcebergen Reports Record Revenue And Diluted Earnings Per Share; Diluted Earnings Per Share Increase 19 Percent And Record Operating Revenue Exceeds $12 Billion
    • Jan 26, 2004: Amerisourcebergen Reports Operating Margin Expansion And Record Diluted Earnings Per Share For The December Quarter
    • Nov 05, 2003: Amerisourcebergen Reports Operating Margin Expansion And Record Diluted Earnings Per Share For The September Quarter And Fiscal Year 2003
    • Jul 24, 2003: Amerisourcebergen Reports Record Operating Revenue And Diluted Earnings Per Share For The June Quarter; Operating Revenue Up 12 Percent, And Diluted Eps Up 21 Percent
    • Apr 24, 2003: Amerisourcebergen Reports Record Operating Revenue And Diluted Earnings Per Share For The March Quarter
    • Mar 13, 2003: Amerisourcebergen Reaffirms Revenue And Earnings Per Share Guidance For The Remainder Of Fiscal Year 2003
    • Jan 24, 2003: Amerisourcebergen Reports Record Revenue And Diluted Earnings Per Share For The December Quarter
    • Nov 05, 2002: Amerisourcebergen Reports Record Earnings Per Share Before Special Charges Of $.88 For The September Quarter And $3.29, A 42 Percent Increase, For Fiscal Year 2002
    • Jul 31, 2002: Amerisourcebergen Reports Earnings Per Share Up 48 Percent To $0.86 Before Special Charges In June Quarter
    • Apr 25, 2002: Amerisourcebergen Reports Record March Quarter As Early Synergy Capture And Interest Savings Drive Results
    • Jan 24, 2002: Amerisourcebergen Reports Record Revenue And Earnings For First Quarter Fiscal Year 2002; First Quarter Eps Up 37 Percent To $0.67 Before Special Item
    • Nov 08, 2001: Amerisourcebergen Reports Record Revenues And Earnings For Fiscal Fourth Quarter And Fiscal Year 2001; Fourth Quarter Eps Up 21 Percent To $0.64 Before Special Items
    • Oct 12, 2001: Amerisourcebergen Announces Date And Time For Earnings Release, Conference Call And Webcast
    • Sep 10, 2001: Amerisourcebergen Provides Update On Integration Plans, Financial Guidance; Company Targets 20% Annual Eps Growth Before Merger And Acquisition Costs
    • Jul 26, 2001: Bergen Brunswig Reports Record Third Quarter Revenues And Operating Earnings June 30, 2001
    • Jul 25, 2001: Amerisource Reports Record Revenues And Earnings For Fiscal Third Quarter; Operating Revenue Up Over 20 Percent, Net Income Up 25 Percent, Eps Hits $.57
    • Jul 09, 2001: Bergen Brunswig Announces Date And Time For Earnings Conference Call And Web Cast
    • Apr 26, 2001: Amerisource Reports Record Revenue And Earnings For Fiscal Second Quarter; Operating Revenue Up 23 Percent, Net Income Up 30 Percent, Eps Hits $.57
    • Apr 03, 2001: Bergen Brunswig Announces Date And Time For Earnings Conference Call And Web Cast
    • Feb 08, 2001: Bergen Brunswig Corporation Announces Results For Pharmerica Quarterly Financial Information Available On Bbc Web Site
    • Feb 01, 2001: Amerisource Reports Record Fiscal First Quarter Revenue And Earnings; Operating Revenue Up 17 Percent, Net Income Up 21 Percent, Eps Hits $.49
    • Jan 15, 2001: Bergen Brunswig Announces Date And Time For Earnings Conference Call And Webcast
    • Nov 02, 2000: Amerisource Reports Record Revenue And Earnings For Fiscal Fourth Quarter And Year 2000
    • Oct 25, 2000: Amerisource Announces Date And Time For Earnings Release, Conference Call And Webcast
    • Jul 27, 2000: Amerisource Reports Record Fiscal Third Quarter Revenues And Earnings; Operating Revenue Up 19 Percent, Eps Increased 23 Percent
    • Apr 27, 2000: Amerisource Reports Record Fiscal Second Quarter Revenues And Earnings
    • Jan 27, 2000: Net Income Up 21% On Revenue Increase Of 20% For Amerisource Health In First Quarter Fiscal 2000
    • Corporate Communications
    • Jul 01, 2011: AmerisourceBergen Appoints Steven Collis As CEO
    • May 12, 2011: AmerisourceBergen Appoints Steven Collis To Board
    • Apr 04, 2011: AmerisourceBergen Names David Neu As President Of ABDC
    • Mar 14, 2011: AmerisourceBergen Names Steven Collis As New CEO
    • Feb 17, 2011: AmerisourceBergen Announces Board Changes
    • Nov 12, 2010: AmerisourceBergen Names Steve Collis As President And COO
    • Aug 03, 2010: AmerisourceBergen Promotes Barbara Brungess To Vice President, Corporate And Investor Relations
    • May 13, 2010: AmerisourceBergen Elects Kathleen Hyle To Board
    • Mar 04, 2010: AmerisourceBergen Re-Elects Richard Gochnauer, Edward Hagenlocker And Henry McGee As Board Members
    • Government and Public Interest
    • Dec 19, 2011: US Bioservices Receives URAC Specialty Pharmacy Accreditation
    • Product News
    • Aug 13, 2001: Family Pharmacy Launches Preferred Rx Options (Prxo) Incentives Program
    • Mar 11, 2004: Amerisourcebergen Helps Hospitals And Manufacturers Respond To New Fda Barcode Regulations With Broadest Array Of Solutions
    • Feb 28, 2000: Amerisource Launches E-Commerce Initiative: Virtual Internet Pharmacy
  • Appendix
  • Methodology
  • About GlobalData
  • Contact Us
  • Disclaimer 113
  • List of Tables
    • AmerisourceBergen Corporation, Pharmaceuticals & Healthcare, Key Facts, 2011
    • AmerisourceBergen Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
    • AmerisourceBergen Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2006 to YTD 2012
    • AmerisourceBergen Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2006 to YTD 2012
    • AmerisourceBergen Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
    • AmerisourceBergen Corporation, Pharmaceuticals & Healthcare Deals By Type, 2006 to YTD 2012
    • AmerisourceBergen Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2006 to YTD 2012
    • AmerisourceBergen Corporation, Deals By Therapy Area, 2006 to YTD 2012
    • AmerisourceBergen Corporation, Medical Devices Deals, 2006 to YTD 2012
    • AmerisourceBergen Corporation, Pharmaceuticals & Healthcare, Partnerships, Deals By Year Vs Deal Value Vs Upfront Payment, 2006 to YTD 2012
    • AmerisourceBergen Corporation, Pharmaceuticals & Healthcare, Partnerships, Deals By Year Vs Deal Value Vs Upfront Payment, 2006 to YTD 2012
    • AmerisourceBergen Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2006 to YTD 2012
    • AmerisourceBergen Forms Joint Venture With Kindred Healthcare
    • Sciele Pharma Partners With AmerisourceBergen
    • AmerisourceBergen Completes Public Offering Of 3.5% Senior Notes Due 2021 For $500 Million
    • AmerisourceBergen Completes Public Offering Of Senior Notes Due 2019 For $400 million
    • AmerisourceBergen Completes Acquisition Of TheraCom For $250 Million
    • AmerisourceBergen Acquires IntrinsiQ For $35 Million
    • AmerisourceBergen Acquires Innomar Strategies
    • AmerisourceBergen Acquires Bellco Health
    • AmerisourceBergen Acquires Xcenda
    • AmerisourceBergen Acquires Access
    • AmerisourceBergen Acquires IgG of America
    • AmerisourceBergen Acquires Health Advocates
    • AmerisourceBergen Acquires Rep-Pharm
    • AmerisourceBergen Acquires Asenda Pharmaceutical
    • AmerisourceBergen Acquires Brecon Pharmaceuticals
    • AmerisourceBergen Acquires Network for Medical Communications & Research
    • AmerisourceBergen Corporation, Key Competitors
    • AmerisourceBergen Corporation, Key Employees
    • AmerisourceBergen Corporation, Other Locations
    • AmerisourceBergen Corporation, Subsidiaries 36
  • List of Figures
    • AmerisourceBergen Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2006 to YTD 2012
    • AmerisourceBergen Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
    • AmerisourceBergen Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2006 to YTD 2012
    • AmerisourceBergen Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2006 to YTD 2012
    • AmerisourceBergen Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2006 to YTD 2012
    • AmerisourceBergen Corporation, Pharmaceuticals & Healthcare, Medical Devices Deals, 2006 to YTD 2012
+44 20 8816 8548

Ask a question about AmerisourceBergen Corporation (ABC) - Pharmaceuticals & Healthcare

Enter the characters you see in the picture below
Captcha